[Research Report] The clinical decision support systems market was valued at US$ 2,120.00 million in 2022, and the clinical decision support systems market size is projected to reach US$ 3,564.00 million by 2030. It is expected to register a CAGR of 10.00% in the forecast period.

Market Insights and Analyst View:

An application that analyzes data to assist healthcare providers in making decisions and enhancing patient care is known as a clinical decision support system (CDSS). It is a variant of the decision support system (DSS), which is frequently employed to assist with the management of businesses. The main goal of a CDSS is to employ knowledge management to obtain clinical recommendations based on a variety of patient-related data elements. Clinical decision support systems facilitate integrated processes, help during patient care, and make suggestions for treatment plans. Data mining can be used with clinical decision support systems to look at a patient's medical history along with pertinent clinical studies. The results of this research can then be used to detect signs of diseases or predict possible events like drug interactions.

Computerized alerts and reminders, clinical recommendations, condition-specific order sets, patient information summaries and records, diagnostic support, documentation templates, and other pertinent reference materials are all included in CDSS solutions. Additional significant advantages provided by CDSS include better health outcomes and higher quality of care, error elimination, cost savings, enhanced productivity, and satisfaction from patients and providers.

Growth Drivers and Opportunities:

The primary drivers of the clinical decision support systems (CDSS) market's growth are the growing need to reduce healthcare costs, the requirement to improve the quality of care, and technological developments in hospital IT. In addition, the Organization for Economic Co-operation and Development (OECD) Survey Report indicates that in Germany, Norway, and Sweden, the average per capita health spending in 2021 was around USD 7,382.6, USD 7,064.8, and USD 6,262.3. Thus, it is anticipated that the high cost of healthcare would also support market expansion. The accuracy, sensitivity, and specificity measurements of the hybrid optimization learning algorithm were reported in the Science Direct study that was released in November 2022. The outcomes showed that the suggested model was consistent with previous research findings and a good fit for the diagnosis of social anxiety disorder. It is anticipated that the clinical decision support systems' efficiency will fuel market expansion.

Furthermore, the market is anticipated to develop as a result of the growing elderly population. The number of people 60 and above is predicted to rise to 1.4 billion in 2030 and 2.1 billion by 2050, according to WHO figures released in October 2022. According to a UN report from 2022, the proportion of people 65 and older is expected to increase from 10% in that year to 16% in 2050. Advanced clinical decision support systems are predicted to be in high demand due to the aging population, which is more likely to develop chronic diseases and require ongoing medical care to prevent illness will propel the market's expansion.

Furthermore, it is anticipated that growing activities such as partnerships and collaborations to create clinical decision support systems will aid in the market's expansion. For example, Google Cloud and the national hospital chain HCA Healthcare entered into a multi-year deal in June 2021 to develop personalized healthcare algorithms that will enhance clinical decision-making.

Therefore, it is anticipated that rising healthcare spending and initiatives to build clinical decision-support systems will drive market expansion. The market's growth is hampered, nevertheless, by a lack of trained personnel, suggestions from CDSS for needless diagnostic tests, and a lack of trust in the systems, given that CDSS is still in the early phases of development.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Clinical Decision Support Systems Market: Strategic Insights

Clinical Decision Support Systems Market

• 
  CAGR (2023 - 2031)

  10.40%
• Market Size 2023
  US$ 4.09 Billion
• Market Size 2031
  US$ 9.02 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Cerner Corporation
• Medical Information Technology, Inc.
• BD
• Wolters Kluwer N.V.
• Baxter International Inc.
• Premier
• Koninklijke Philips N.V.
• RELX (Elseiver)
• PeraHealth

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Model

• Knowledge-based CDSS and Non-knowledge CDSS

Mode of Delivery

• Cloud-based and On-premise

Component

• Hardware
• Software
• Services

Product

• Integrated CDSS and Standalone CDSS

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Report Segmentation and Scope:

The “Global clinical decision support systems” are segmented based on the model, mode of delivery, component, product, application, and region. The model segment of the clinical decision support systems market is broadly segmented into knowledge-based CDSS and non-knowledge CDSS. The clinical decision support systems market is classified on the basis of mode of delivery, such as cloud-based and on-premise. The component segment of the clinical decision support systems market is broadly segmented into hardware, software, and services. Based on the product, the market is classified into integrated CDSS and standalone CDSS. On the basis of application, the clinical decision support systems market is segmented into medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other applications. The clinical decision support systems market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

Based on the model, the clinical decision support systems market is segmented into Knowledge-based CDSS and Non-knowledge CDSS. In 2022, the Clinical Decision Support Systems market revenue was mostly attributed to the Knowledge-Based CDSS segment, which had the largest share. The Knowledge-Based CDSS's has numerous benefits. Its capacity to support physicians' clinical judgments in the face of uncertainty by applying Knowledge-Based reasoning can be attributed to the market's size and high proportion. The second fastest-growing sector in the Clinical Decision Support Systems market, non-knowledge-based CDSS, makes up a sizeable portion of the market. Non-knowledge-based CDSS still require a data source, but instead of being designed to follow expert medical knowledge, they use artificial intelligence (AI), machine learning (ML), or statistical pattern recognition to make their decisions.

Based on the mode of delivery, the clinical decision support systems market is segmented into cloud-based and on-premise. The two main factors propelling the growth of the cloud-based market segment are rising healthcare costs and cloud computing use. The governments of several European nations are launching programs to encourage the development of information technology in the medical field. For example, the UK government started a project in February 2021 to implement a fully integrated cloud-driven health service. More than two million National Health Services (NHS) emails were transferred to Microsoft's Azure Cloud as a result of this effort. Improved information availability and more seamless and effective staff communication between departments and organizations within the NHS will result from this will accelerate the expansion of the market and raise the use of (Healthcare Information Technology) HCIT Change Management services in the United Kingdom.

On the basis of components, the clinical decision support systems market is classified into hardware, software, and services. In 2022, the services sector accounted for the majority of market revenue. The useful information base and frequent program changes are to blame for this. Maintenance services for parts and their accessories are included in CDSS services. It provides software and hardware updates, along with a knowledge library containing the most recent medications and discoveries. With the quickest rate of growth, the Clinical Decision Support Systems market is dominated by the software category. When combined with CPOE and EHR software, the CDSS software provides better decision support by creating customized and unique results for each patient.

Regional Analysis:

Based on geography, the global clinical decision support systems market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

The market for clinical decision support systems (CDSS) in North America is driven by growing patient awareness, increasing investments in healthcare IT solutions, and technological advancements in CDSS. The government's increasing support for healthcare in North America is another element contributing to the market's expansion in the US. For instance, the Congressional Budget Office (2021) reported that federal spending for the National Institute of Health (NIH) had exceeded USD 700 billion during the previous few decades.

Furthermore, the market is anticipated to develop as a result of the increasingly sophisticated products that different market competitors are likely to launch in this area. First Databank, Inc., for example, debuted the FDB CDS Analytics in August 2021 at the 2021 HIMSS Global Conference and Exhibition in Las Vegas. With the help of this technology, healthcare provider organizations may quickly locate, track, and alter clinical decision support within their EHR.

Furthermore, Pathway, a Canadian healthcare startup that provides providers with evidence-based clinical support, raised USD 1.3 million in its first financing round in June 2021. The company wanted to improve clinical decision support technologies with this funding in order to boost healthcare efficiency eventually. The above factors, which include rising investments, the introduction of CDSS, and substantial financing for healthcare, could propel the CDSS market's expansion in North America during the projected year.

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global clinical decision support systems market are listed below:

1. In January 2023, Grand River Hospital launched Signal 1's AI-Powered Clinical Decision Support System. In order to customize and improve Signal 1's offering for Grand River Hospital's patient demographic and clinical procedures, clinical teams at the hospital worked with Signal 1 for several months prior to the product's introduction. The CAN Health Network is funding this work.
2. In August 2022, With the launch of InterQual 2022, Change Healthcare improved clinical decision support by utilizing the most recent technology and evidence-based standards.
3. In June 2022, The clinical decision support system was introduced by nView Health to assist in diagnosing, treating, and keeping an eye on mental disease. In order to track advancement, the nView solution employed a measurement-based care process model that included screening, evaluation, clinical follow-up and severity, and outcome monitoring.
4. In August 2021, During the 2021 HIMSS Global Conference & Exhibition in Las Vegas, FDB, the preeminent source of drug and medical device expertise that supports healthcare professionals in making informed decisions, introduced FDB CDS Analytics. In order to improve patient outcomes, the solution helps healthcare provider organizations identify, track, and customize clinical decision support (CDS) in their electronic health record (EHR). This, in turn, improves clinician user experiences and advances CDS impact across all care areas.
5. In June 2021, The white paper Clinical Decision Support: Leveraging Technology to Drive Outcomes and Efficiencies was launched today by Altera Digital Health, Inc. and the American Health Information Management Association (AHIMA). Faster decision-making, more efficiency, and better patient outcomes were reported by a panel of doctors and health information specialists who discussed the effects of enhanced clinical decision support (CDS) on clinical workflow and satisfaction.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global clinical decision support systems market are Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, Zynx Health and amongst others. These clinical decision support systems market focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share. The report offers clinical decision support systems market trends analysis emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Clinical Decision Support Systems Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.